David G. Lowe, a California venture capitalist, and his wife were house hunting last week in Austin.
Lowe, CEO of Austin startup Aeglea BioTherapeutics, planned his move before Texas Gov. Rick Perry’s latest overture to Californians trying to escape higher taxes and greater regulation.
The story you’re reading is premium content from the Austin American-Statesman. Subscribers get total access to all our in-depth news, digital editions and exclusive premium content. You can also buy a 24-hour digital pass or 7-day digital pass.
Read MyStatesman.com now — 24-hour digital pass99¢ for 24-hours
Read MyStatesman.com all week — 7-day digital pass$3.99 for 7-days
Subscribe to the Statesman for as little as 33¢ per dayView Offers
For Subscribers: Register your account for digital access.Access Digital
For Subscribers: Sign in here if you have already registered your account.Sign In
In 2007, Texas voters approved $3 billion in bonds to finance a 10-year effort to find cures and therapies for various cancers. As of December, the Cancer Prevention and Research Institute of Texas — commonly known as CPRIT — has awarded $836 million.
So far, 76 percent of the money has gone to research, 21 percent to prevention programs and 3 percent to product development.
Forty-four researchers also have been persuaded to relocate their labs and teams to Texas.